Use of targeted agents in elderly cancer patients (ECP) according to the Comprehensive Geriatric Assessment (CGA)

Lucia Fratino,Alessandra Bearz,Cecilia Simonelli,Annalisa Giacalone,Ivana Sartor,Anna Maria Colussi,Massimiliano Berretta,Emanuela Vaccher,Michele Spina,Umberto Tirelli

Use of targeted agents in elderly cancer patients (ECP) according to the Comprehensive Geriatric Assessment (CGA)

2008

Lucia Fratino
Alessandra Bearz
Cecilia Simonelli
Annalisa Giacalone
Ivana Sartor
Anna Maria Colussi
Massimiliano Berretta
Emanuela Vaccher
Michele Spina
Umberto Tirelli

20619 Background: Epidermal Growth Factor Receptor (EGFR) inhibitors (Gefitinib and Erlotinib) increase the survival of NSCLC patients, while Sorafenib has clinical activity in advanced renal cell ...

Keywords:

Physical therapy
Cancer
Medicine
Internal medicine
Cell
Oncology
Erlotinib
geriatric assessment
Epidermal growth factor receptor
Gefitinib
Sorafenib
Gerontology
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations